Sente, Inc., recently announced the appointment of Michael York as president, chief executive officer and a member of the board of directors. York joins Sente after more than 20 years in management and leadership positions at Amylin Pharmaceuticals; Santarus, Inc.; Amgen; and AstraZeneca. Want to read more? Subscribe to one of our monthly plans to continue reading this article.